1. Li, Ying-Qing, Chen, Yang, Xu, Ya-Fei, Tang, Ling-Long, Liu, Na. 2020. FNDC3B 3'-UTR shortening escapes from microRNA-mediated gene repression and promotes nasopharyngeal carcinoma progression. In Cancer science, 111, 1991-2003. doi:10.1111/cas.14394. https://pubmed.ncbi.nlm.nih.gov/32232887/
2. Wiggs, Janey L, Pasquale, Louis R. . Genetics of glaucoma. In Human molecular genetics, 26, R21-R27. doi:10.1093/hmg/ddx184. https://pubmed.ncbi.nlm.nih.gov/28505344/
3. Mannan, Abdul, Muhsen, Ibrahim N, Barragán, Eva, Hashmi, Shahrukh K, Aljurf, Mahmoud. 2020. Genotypic and Phenotypic Characteristics of Acute Promyelocytic Leukemia Translocation Variants. In Hematology/oncology and stem cell therapy, 13, 189-201. doi:10.1016/j.hemonc.2020.05.007. https://pubmed.ncbi.nlm.nih.gov/32473106/
4. Li, Congya, Ding, Linchao, Wang, Xuyao, Liu, Jian, Zhu, Junlan. 2023. A RBM47 and IGF2BP1 mediated circular FNDC3B-FNDC3B mRNA imbalance is involved in the malignant processes of osteosarcoma. In Cancer cell international, 23, 334. doi:10.1186/s12935-023-03175-3. https://pubmed.ncbi.nlm.nih.gov/38129874/
5. Wang, Xiao, Huang, Yeping, Li, Shanshan, Zhang, Hong. 2022. Integrated machine learning methods identify FNDC3B as a potential prognostic biomarker and correlated with immune infiltrates in glioma. In Frontiers in immunology, 13, 1027154. doi:10.3389/fimmu.2022.1027154. https://pubmed.ncbi.nlm.nih.gov/36275754/
6. Hua, Kate, Wu, Chen-Tang, Lin, Chin-Hui, Chen, Chian-Feng. 2024. E2F1 promotes cell migration in hepatocellular carcinoma via FNDC3B. In FEBS open bio, 14, 687-694. doi:10.1002/2211-5463.13783. https://pubmed.ncbi.nlm.nih.gov/38403291/
7. Han, Bing, Wang, Hongbo, Zhang, Jianzhao, Tian, Jingwei. 2019. FNDC3B is associated with ER stress and poor prognosis in cervical cancer. In Oncology letters, 19, 406-414. doi:10.3892/ol.2019.11098. https://pubmed.ncbi.nlm.nih.gov/31897153/
8. Liu, Yu-Ying, Zhang, Yu-Ying, Ran, Ling-Yu, Qin, Chang-Hong, Xiao, Bin. 2024. A novel protein FNDC3B-267aa encoded by circ0003692 inhibits gastric cancer metastasis via promoting proteasomal degradation of c-Myc. In Journal of translational medicine, 22, 507. doi:10.1186/s12967-024-05225-4. https://pubmed.ncbi.nlm.nih.gov/38802851/